Is the use of HBMP effective in preventing thrombotic events in hospitalized oncology patients?
Year: 2026
Type: article
Abstract: No direct evidence for the use of HBMP in preventing thrombotic events in hospitalized oncology patients was identified. Existing guidelines recommend LMWH and DOACs for VTE prevention, highlighting the need for further research to optimize thromboprophylactic strategies in this population.
Author: Tripdatabase
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235914634
